An AI model developed by researchers at Rochester, Minn.-based Mayo Clinic detected pancreatic cancer on abdominal CT scans taken up to three years before clinical diagnosis, according to a study published April 28 in Gut. The model, called the Radiomics-based…
The Latest
Omaha, Neb.-based Fred & Pamela Buffett Cancer Center has launched two data visualization tools to provide insight into cancer incidence and demographic risk factors in Nebraska. The Cancer InFocus Data Dashboard provides county- and state-level data on cancer incidence, screening…
Analyzing multiple photos from across an oncology patient’s course of treatment with AI may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found. Researchers behind FaceAge, which uses AI to…
A group of leaders from New York City-based Memorial Sloan Kettering Cancer Center, Boston-based Massachusetts General Hospital and Stanford (Calif.) University are calling for academic medical centers to rethink their well-established model of drug discovery and development to stay competitive…
The FDA has launched its first two real-time clinical trials in partnership with Houston-based University of Texas MD Anderson Cancer Center, Philadelphia-based University of Pennsylvania, AstraZeneca, Amgen and Paradigm Health. The real-time clinical trial model allows the FDA to review…
The perioperative environment is one of the largest untapped sources of financial and operational improvement in health systems — and most organizations still aren’t capturing it. Unwarranted clinical variation, misaligned supply chain strategy and siloed decision-making quietly erode margins without…
Jun 4, 2026 11:00 AM - 12:00 PM CDT
Presented by:
Presenters
Dawn Perryman
Associate Vice President, Perioperative Supply Chain Solutions, Vizient, Inc.
Rene Gurdian Jr., MBA
Vice President, SCM Data Analytics and Transformation Ochsner Health
Nattie Leger, MSN, RN, LSSBB
Vice President, Supply Chain Value & Clinical Performance Ochsner Health
Infusion centers are caught between climbing oncology volume, a workforce that hasn’t rebounded post-pandemic, and margin discipline that rules out the old answer of more chairs and more nurses. The operational lever has shifted to better demand pacing and more…
An underrecognized, genetically inherited risk factor may be quietly accelerating cardiovascular disease in patients you’re already treating — and routine workups won’t catch it. Lipoprotein(a), or Lp(a), has an emerging and increasingly documented role in aortic stenosis and peripheral arterial…
On Demand
Presented by:
Presenters
Dr. Marc P. Bonaca MD, MPH, FACC, FAHA
Executive Director of Colorado Prevention Center, Aurora, CO, USA Director of Vascular Research, Tenured Professor of Medicine, University of Colorado Anschutz, Aurora, CO, USA Chair of the AHA PAD Collaborative Past Chair of the ACC Vascular Disease Section Leadership Council
Nishant Shah, MD
Assistant Professor, Medicine and Cardiovascular Disease Prevention Lead for the Duke Health System Remote Lipid Monitoring Program Clinical lead in the implementation of Inclisiran across Duke Health System DCRI for a study that evaluates the effectiveness of PCSK9 inhibitors in the Prevention of Cardiovascular Disease
Lp(a) is one of the most clinically meaningful — and most under-tested — cardiovascular risk factors in routine practice. Inaccurate assays, inconsistent reporting standards and disparities in testing across patient populations leave many at-risk patients undiagnosed and undertreated. This on-demand…
On Demand
Presented by:
Presenters
Howard S. Weintraub, MD, FACC, FAHA, FASPC
Clinical Professor of Medicine, NYU Grossman School of Medicine Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
Leslie J. Donato, Ph.D., D(ABCC)
Co-Director Clinical Specialty Laboratory Co-Director Hospital Clinical Laboratory and Point of Care Associate Professor, Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology at Mayo Clinic
U.S. hospitals are under pressure from every direction — cost constraints, supply chain instability, cybersecurity threats and the push to integrate AI responsibly. The question isn’t whether to adapt. It’s how. In this webinar a global medtech CEO shares how…
May 20, 2026 1:00 PM - 2:00 PM CDT
Presented by:
Presenters
Britt Meelby Jensen
CEO, Ambu